LexIA

Aviso: esto no es asesoría legal. LexIA solo organiza fuentes públicas y puede estar incompleto.

U.S. Code · Título 21

Prescription drug take back expansion

21 U.S.C. § 822a

Office of the Law Revision Counsel · release 119-142

Texto oficial en GovInfo

Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.

Capítulo 13

(a)

Definition of covered entity

In this section, the term “covered entity” means—

(1) a State, local, or tribal law enforcement agency;
(2) a manufacturer, distributor, or reverse distributor of prescription medications;
(3) a retail pharmacy;
(4) a registered narcotic treatment program;
(5) a hospital or clinic with an onsite pharmacy;
(6) an eligible long-term care facility; or
(7) any other entity authorized by the Drug Enforcement Administration to dispose of prescription medications.
(b)

Program authorized

The Attorney General, in coordination with the Administrator of the Drug Enforcement Administration, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, shall coordinate with covered entities in expanding or making available disposal sites for unwanted prescription medications.

(Pub. L. 114–198, title II, § 203, July 22, 2016, 130 Stat. 717.)